Immune Cell Metabolism in Tumor Microenvironment

被引：26
作者：
Li, Yongslieng [1 ]
Wan, Yisong Y. [2 ]
Zhu, Bo [1 ]
机构：
[1] Third Mil Med Univ, Xinqiao Hosp, Inst Canc, Chongqing, Peoples R China
[2] Univ North Carolina Chapel Hill, Lineberger Comprehen Canc Ctr, Chapel Hill, NC USA
来源：
IMMUNE METABOLISM IN HEALTH AND TUMOR | 2017年 / 1011卷
关键词：
Immune cell metabolism; Tumor microenvironment; Cancer stein cells; Clinical diagnosis; Drug repositioning; FATTY-ACID OXIDATION; CANCER-ASSOCIATED FIBROBLASTS; HUMAN DENDRITIC CELLS; REGULATORY T-CELLS; PYRUVATE-KINASE M2; SUPPRESSOR-CELLS; NITRIC-OXIDE; MACROPHAGE POLARIZATION; ALTERNATIVE ACTIVATION; GLUTAMINE-METABOLISM;
D O I：
10.1007/978-94-024-1170-6_5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Tumor microenvironment (TME) is composed of tumor cells, immune cells, cytokines, extracellular matrix, etc. The immune system and the metabolisms of glucose, lipids, amino acids, and nucleotides are integrated in the tumorigenesis and development. Cancer cells and immune cells show metabolic reprogramming in the TME, which intimately links immune cell functions and edits tumor immunology. Recent findings in immune cell metabolism hold the promising possibilities toward clinical therapeutics for treating cancer. This chapter introduces the updated understandings of metabolic reprogramming of immune cells in the TME and suggests new directions in manipulation of immune responses for cancer diagnosis and therapy.
引用
收藏
页码：163 / 196
页数：34
相关论文
共 265 条
  • [61] Inhibition of Tumor Growth and Alteration of Associated Macrophage Cell Type by an HO-1 Inhibitor in Breast Carcinoma-Bearing Mice
    Deng, Rui
    Wang, Shi-Min
    Yin, Tao
    Ye, Ting-Hong
    Shen, Guo-Bo
    Li, Ling
    Zhao, Jing-Yi
    Sang, Ya-Xiong
    Duan, Xiao-Gang
    Wei, Yu-Quan
    [J]. ONCOLOGY RESEARCH, 2012, 20 (10) : 473 - 482
  • [62] Cancer Neoantigens and Applications for Immunotherapy
    Desrichard, Alexis
    Snyder, Alexandra
    Chan, Timothy A.
    [J]. CLINICAL CANCER RESEARCH, 2016, 22 (04) : 807 - 812
  • [63] Metabolic influences that regulate dendritic cell function in tumors
    Dong, Han
    Bullock, Timothy N. J.
    [J]. FRONTIERS IN IMMUNOLOGY, 2014, 5
  • [64] Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-specific immune responses and tumor eradication
    Draghiciu, Oana
    Nijman, Hans W.
    Hoogeboom, Baukje Nynke
    Meijerhof, Tjarko
    Daemen, Toos
    [J]. ONCOIMMUNOLOGY, 2015, 4 (03): : 1 - 11
  • [65] Immature, semi-mature, and fully mature dendritic cells: toward a DC-cancer cells interface that augments anticancer immunity
    Dudek, Aleksandra M.
    Martin, Shaun
    Garg, Abhishek D.
    Agostinis, Patrizia
    [J]. FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [66] Tumor Endothelial Cells
    Dudley, Andrew C.
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2012, 2 (03):
  • [67] The three Es of cancer immunoediting
    Dunn, GP
    Old, LJ
    Schreiber, RD
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 : 329 - 360
  • [68] Interacting mast cells and eosinophils acquire an enhanced activation state in vitro
    Elishmereni, M.
    Bachelet, I.
    Ben Efraim, A. H. Nissim
    Mankuta, D.
    Levi-Schaffer, F.
    [J]. ALLERGY, 2013, 68 (02) : 171 - 179
  • [69] Alternatively Activated Macrophage Possess Antitumor Cytotoxicity That Is Induced by IL-4 and Mediated by Arginase-1
    Ellyard, Julia I.
    Quah, Ben J. C.
    Simson, Ljubov
    Parish, Christopher R.
    [J]. JOURNAL OF IMMUNOTHERAPY, 2010, 33 (05) : 443 - 452
  • [70] TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKε supports the anabolic demands of dendritic cell activation
    Everts, Bart
    Amiel, Eyal
    Huang, Stanley Ching-Cheng
    Smith, Amber M.
    Chang, Chih-Hao
    Lam, Wing Y.
    Redmann, Veronika
    Freitas, Tori C.
    Blagih, Julianna
    van der Windt, Gerritje J. W.
    Artyomov, Maxim N.
    Jones, Russell G.
    Pearce, Erika L.
    Pearce, Edward J.
    [J]. NATURE IMMUNOLOGY, 2014, 15 (04) : 323 - +
234567891011